Search

everythinglearnresearchcommunity

for

Search:↓

The document reports unique growth lines in a child after Stevens-Johnson syndrome, skin reaction from parsnips and sun in a girl, and itchy skin with xanthomas in a boy with Alagille syndrome.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Finasteride exposure in pregnancy causes genital abnormalities in male rats.

Finasteride affects male rat genitalia development, causing abnormalities during specific pregnancy days.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Chemotherapy often causes skin, nail, and hair side effects, significantly impacting quality of life.

Toxic Shock Syndrome cases increased due to new factors, but decreased with public health measures and changes in tampon use.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Mice healed without scars as fetuses but developed scars as adults, suggesting scarless healing might be replicated with further research.

Antidepressants called SSRIs can cause skin problems, bleeding risk, and other side effects.

Alefacept may effectively treat severe lichen planus, with patients showing significant improvement and no side effects.

The method effectively identifies banned substances in hair loss and skin disease cosmetics.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

3D-printed mesoporous scaffolds show promise for personalized drug delivery with controlled release.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

A woman developed male traits from accidental contact with her husband's testosterone gel.

EF and PXE not closely related.

An alpaca acted like a male and couldn't have babies because of a benign tumor in its ovary that caused high testosterone levels.

Secondary aesthetic surgeries for gender reassignment are generally satisfying and advance overall aesthetic surgery techniques, but psychological support is important.

Older women often have vulva issues due to less estrogen, which can be misdiagnosed and lead to wrong treatments.

The document suggests a young mother use effective contraception like the Copper-T IUD while considering her health and the need for STD prevention.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.